Express News | Telomir Pharmaceuticals Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing
Telomir Pharmaceuticals | 10-K: FY2024 Annual Report
Telomir Pharmaceuticals Announces Results From Preclinical Studies of Telomir-1
Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses
Express News | Telomir Pharmaceuticals Inc - Telomir-1 Reverses Copper-Induced Ros Elevation in Human Cell Lines
Express News | Telomir Pharmaceuticals Inc - Announces Breakthrough Results With Telomir-1
Telomir Touts Potential of Telomir-1 in Addressing Oxidative Stress
Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) Biggest Owners Are Retail Investors Who Got Richer After Stock Soared 13% Last Week
Renovaro Names Nathen Fuentes as CFO
Telomir Pharmaceuticals Shares Are Trading Higher After the Company Announced Potentially Groundbreaking Findings From a Preclinical Progeria Lifespan Study.
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
Express News | Telomir Pharmaceuticals: Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria
Express News | Telomir Pharmaceuticals Inc - to Submit Ind & Inad Application by Q4 2025, With Clinical Trials Planned for 2026
EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease
Express News | Telomir Pharmaceuticals Shares Down 12.57% at $4.45 in Premarket Trade; White Diamind Research Says It Has a Strong Sell Rating on the Stock
Express News | Telomir Pharmaceuticals Announced It Raised $1M In Equity Funding Through Starwood Trust
Telomir Pharmaceuticals Enters Into Stock Purchase Agreement
Telomir Pharmaceuticals Raises $1M At $7 Per Share In No-warrant, Restricted Common Stock Deal - Filing
Individual Investors Are Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) Biggest Owners and Were Rewarded After Market Cap Rose by US$75m Last Week
Why Is Telomir Pharmaceuticals Stock Trading Higher On Tuesday?